104 related articles for article (PubMed ID: 1703165)
21. Increased detection of specific tyrosine phosphoproteins correlates with tumor progression of Abelson virus-infected lymphocytes.
Clark SS; Liang Y
Leukemia; 1995 Jan; 9(1):165-74. PubMed ID: 7845013
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow-transforming activity of linker insertion mutants of Abelson murine leukemia virus.
Hevezi P; Alin K; Rees-Jones R; Goff SP
Oncogene; 1992 Nov; 7(11):2323-8. PubMed ID: 1437154
[TBL] [Abstract][Full Text] [Related]
23. Reversion to the nontransformed phenotype of Abelson murine leukemia virus-transformed cells and their subsequent retransformation.
Roebroek AJ; Bloemers HP; van de Ven WJ
Virus Res; 1986 Oct; 6(1):15-26. PubMed ID: 2432738
[TBL] [Abstract][Full Text] [Related]
24. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
Warren D; Griffin DS; Mainville C; Rosenberg N
J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of temperature-sensitive mutants of Abelson murine leukaemia virus that exhibit dissociation among morphological transformation, soft agar colony-forming ability and tyrosine kinase activity.
Oka Y; Sugiyama H; Tsukada S; Shimizu Y; Inoue H; Hakura A; Kishimoto S
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2527-32. PubMed ID: 2550581
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry of v-Abl transformed pre-B cells heterogeneous in ectopic expression levels reveals Ras dose-response.
Peacock RW; Lawhorn IE; Ferreira JP; Wang CL
J Immunol Methods; 2012 Oct; 384(1-2):177-83. PubMed ID: 22835434
[TBL] [Abstract][Full Text] [Related]
27. Multiple steps are required for the induction of tumors by Abelson murine leukemia virus.
Green PL; Kaehler DA; Bennett LM; Risser R
J Virol; 1989 May; 63(5):1989-94. PubMed ID: 2539498
[TBL] [Abstract][Full Text] [Related]
28. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
Clark SS; Liang Y; Reedstrom CK; Wu SQ
Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
[TBL] [Abstract][Full Text] [Related]
29. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
31. Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts.
Rohrschneider LR; Najita LM
J Virol; 1984 Aug; 51(2):547-52. PubMed ID: 6086963
[TBL] [Abstract][Full Text] [Related]
32. Abelson murine leukemia virus: structural requirements for transforming gene function.
Srinivasan A; Dunn CY; Yuasa Y; Devare SG; Reddy EP; Aaronson SA
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5508-12. PubMed ID: 6291048
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.
Renshaw MW; Kipreos ET; Albrecht MR; Wang JY
EMBO J; 1992 Nov; 11(11):3941-51. PubMed ID: 1396587
[TBL] [Abstract][Full Text] [Related]
34. Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line.
Cook WD; Fazekas de St Groth B; Miller JF; MacDonald HR; Gabathuler R
Mol Cell Biol; 1987 Jul; 7(7):2631-5. PubMed ID: 3039352
[TBL] [Abstract][Full Text] [Related]
35. Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.
Wang JY; Baltimore D
Mol Cell Biol; 1983 May; 3(5):773-9. PubMed ID: 6306446
[TBL] [Abstract][Full Text] [Related]
36. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
Jacobsen EA; Ananieva O; Brown ML; Chang Y
J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
[TBL] [Abstract][Full Text] [Related]
37. DNase I sensitivity of immunoglobulin light chain genes in Abelson murine leukemia virus transformed pre-B cell lines.
Persiani DM; Selsing E
Nucleic Acids Res; 1989 Jul; 17(13):5339-48. PubMed ID: 2548157
[TBL] [Abstract][Full Text] [Related]
38. Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene.
Chung SW; Wong PM; Durkin H; Wu YS; Petersen J
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1585-9. PubMed ID: 1996361
[TBL] [Abstract][Full Text] [Related]
39. Mutations affecting the MA portion of the v-Abl protein reveal a conserved role of Gag in Abelson murine leukemia virus (MLV) and Moloney MLV.
Yi CR; Rosenberg N
J Virol; 2008 Jun; 82(11):5307-15. PubMed ID: 18367522
[TBL] [Abstract][Full Text] [Related]
40. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
Gong L; Unnikrishnan I; Raghavan A; Parmar K; Rosenberg N
J Virol; 2004 Feb; 78(4):1636-44. PubMed ID: 14747529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
